Literature DB >> 31032843

The structure of amyloid-β dimers in Alzheimer's disease brain: a step forward for oligomers.

Randall J Bateman1,2,3, Kwasi G Mawuenyega1, Norelle C Wildburger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31032843      PMCID： PMC6487336          DOI： 10.1093/brain/awz082

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  10 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 2.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

3.  A specific amyloid-beta protein assembly in the brain impairs memory.

Authors:  Sylvain Lesné; Ming Teng Koh; Linda Kotilinek; Rakez Kayed; Charles G Glabe; Austin Yang; Michela Gallagher; Karen H Ashe
Journal:  Nature       Date:  2006-03-16       Impact factor: 49.962

4.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

5.  Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.

Authors:  Ganesh M Shankar; Shaomin Li; Tapan H Mehta; Amaya Garcia-Munoz; Nina E Shepardson; Imelda Smith; Francesca M Brett; Michael A Farrell; Michael J Rowan; Cynthia A Lemere; Ciaran M Regan; Dominic M Walsh; Bernardo L Sabatini; Dennis J Selkoe
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

6.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease.

Authors:  P V Arriagada; J H Growdon; E T Hedley-Whyte; B T Hyman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains.

Authors:  Akihiko Noguchi; Satoko Matsumura; Mari Dezawa; Mari Tada; Masako Yanazawa; Akane Ito; Manami Akioka; Satoru Kikuchi; Michio Sato; Shouji Ideno; Munehiro Noda; Atsushi Fukunari; Shin-ichi Muramatsu; Yutaka Itokazu; Kazuki Sato; Hitoshi Takahashi; David B Teplow; Yo-ichi Nabeshima; Akiyoshi Kakita; Kazutomo Imahori; Minako Hoshi
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

9.  Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.

Authors:  Yuesong Gong; Lei Chang; Kirsten L Viola; Pascale N Lacor; Mary P Lambert; Caleb E Finch; Grant A Krafft; William L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

10.  Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains.

Authors:  Thomas J Esparza; Norelle C Wildburger; Hao Jiang; Mihika Gangolli; Nigel J Cairns; Randall J Bateman; David L Brody
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379
  10 in total
  1 in total

Review 1.  Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies.

Authors:  Hai Yang; Jinping Li; Xiaoxiong Li; Linqiu Ma; Mingliang Hou; Huadong Zhou; Rui Zhou
Journal:  Front Mol Neurosci       Date:  2022-08-31       Impact factor: 6.261
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.